Satter Muneer A 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:00 pm Purchase | 2023-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 16,205,119 8.600% | 1,115,000 (+7.39%) | Filing |
| 2023-02-10 1:08 pm Purchase | 2022-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 15,090,119 8.200% | 1,225,789 (+8.84%) | Filing |
| 2022-12-19 4:10 pm Purchase | 2022-12-08 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 13,864,330 7.500% | 10,797,287 (+352.04%) | Filing |